Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI) -- Ignore unavailable to you. Want to Upgrade?

To: Jim Spitz who wrote (926)	5/30/2001 1:21:48 PM
From: OldAIMGuy	Read Replies (1) \| Respond to of 1154

Hi Jim, The stock is showing greater strength here than I would have expected. I would have thought it would at least drop back to single digits. In the mean time, I've kept to my program of selling off premium shares and holding the core value. Building a cash cushion with the nice rise we've had felt good. In a fashion, one could consider my selling into strength a form or "shorting." My selling in some infinitesimal way affects supply and demand. I have my "buy resistance" set quite high on GENE right now. That's because the cash reserves are rather thin as of yet. So, I won't recirculate that cash until we see a sizable pull-back from the current prices. RE: Short Interest. It looks like this particular volume increase on the decline was all driven by that bit of review by Anthony. What's hard to figure is why a relatively obscure analyst from an equally small investment house's opinion on the company is being singled out as the "reason" for the price rise. I would have thought that it was GENE's presentation early last week at a tech. conference. Maybe there was more than one analyst in the crowd. "Genome Therapeutics to Present at Friedman Billings Ramsey Technology and Growth Investor Conference Date: 5/20/01" ir.ccbn.com In any case, it has made for some profitable LIFO gains for me. Long term the account's still quite profitable as well. Best regards, Tom